Terns Pharmaceuticals (TERN) Operating Expenses (2020 - 2022)
Historic Operating Expenses for Terns Pharmaceuticals (TERN) over the last 3 years, with Q4 2022 value amounting to $16.8 million.
- Terns Pharmaceuticals' Operating Expenses rose 1310.66% to $16.8 million in Q4 2022 from the same period last year, while for Sep 2023 it was $16.8 million, marking a year-over-year decrease of 7199.02%. This contributed to the annual value of $101.9 million for FY2024, which is 66.99% down from last year.
- As of Q4 2022, Terns Pharmaceuticals' Operating Expenses stood at $16.8 million, which was up 1310.66% from $17.3 million recorded in Q3 2022.
- Terns Pharmaceuticals' 5-year Operating Expenses high stood at $17.3 million for Q3 2022, and its period low was $8.7 million during Q3 2020.
- Over the past 3 years, Terns Pharmaceuticals' median Operating Expenses value was $12.6 million (recorded in 2021), while the average stood at $12.5 million.
- As far as peak fluctuations go, Terns Pharmaceuticals' Operating Expenses soared by 6968.52% in 2021, and later soared by 397.86% in 2022.
- Quarter analysis of 3 years shows Terns Pharmaceuticals' Operating Expenses stood at $8.8 million in 2020, then surged by 69.69% to $14.9 million in 2021, then grew by 13.11% to $16.8 million in 2022.
- Its Operating Expenses was $16.8 million in Q4 2022, compared to $17.3 million in Q3 2022 and $14.1 million in Q2 2022.